Article
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.
Blood - 29 Nov 2012
Nieters Alexandra, Conde Lucia, Slager Susan L, Brooks-Wilson Angela, Morton Lindsay, Skibola Danica R, Novak Anne J, Riby Jacques, Ansell Stephen M, Halperin Eran, Shanafelt Tait D, Agana Luz, Wang Alice H, De Roos Anneclaire J, Severson Richard K, Cozen Wendy, Spinelli John, Butterbach Katja, Becker Nikolaus, de Sanjose Silvia, Benavente Yolanda, Cocco Pierluigi, Staines Anthony, Maynadié Marc, Foretova Lenka, Boffetta Paolo, Brennan Paul, Lan Qing, Zhang Yawei, Zheng Tongzhang, Purdue Mark, Armstrong Bruce, Kricker Anne, Vajdic Claire M, Grulich Andrew, Smith Martyn T, Bracci Paige M, Chanock Stephen J, Hartge Patricia, Cerhan James R, Wang Sophia S, Rothman Nathaniel, Skibola Christine F
Abstract excerpt
Many common genetic variants have been associated with non-Hodgkin lymphoma (NHL), but individual study results are often conflicting. To confirm the role of putative risk alleles in B-cell NHL etiology, we performed a validation genotyping study of 67 candidate single nucleotide polymorphisms within InterLymph, a large international consortium of NHL case-control studies. A meta-analysis was performed on data...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.